Hallervorden‐Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus
The DOI matches its Crossref record.
Abstract
We describe neurochemical abnormalities found in the brains of 2 patients with autopsy‐confirmed Hallervorden‐Spatz (HS) disease. In 1 patient, contents of cystine and of glutathione‐cysteine mixed disulfide in the globus pallidus were markedly elevated above values for appropriate control subjects. Activity of cysteine dioxygenase, which converts cysteine to cysteine sulfinic acid, was reduced in the globus pallidus, but normal in the frontal cortex and putamen of both patients. γ‐Aminobutyric acid content was markedly decreased in the globus pallidus and substantia nigra of both patients. These results suggest that cysteine accumulates locally in the globus pallidus in Hallervorden‐Spatz disease as a result of an enzymatic block in the metabolic pathway from cysteine to taurine. Accumulated cysteine may chelate iron, accounting for the local increase in iron content in Hallervorden‐Spatz disease. The combined excess of cysteine and ferrous iron may generate free radicals that damage neuronal membranes to cause the typical morphological changes observed in this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Mammalian Cysteine Metabolism: New Insights into Regulation of Cysteine Metabolism
Stipanuk, M. H., Dominy, J. E., Lee, J.-I., & Coloso, R. M. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1652s · Cited by 543
l‐Cysteine metabolism and its nutritional implications
Yin, J., Ren, W., Yang, G., Duan, J., Huang, X., Fang, R., Li, C., Li, T., Yin, Y., Hou, Y., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500031 · Cited by 353
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 340
Neurodegeneration with brain iron accumulation
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00019-1 · Cited by 317
Mechanisms of L-Cysteine Neurotoxicity
Janáky, R., Varga, V., Hermann, A., Saransaari, P., & Oja, S. S. (2000) · Neurochemical Research · doi:10.1023/a:1007616817499 · Cited by 291
Rouault, T. A., & Cooperman, S. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.002 · Cited by 280
Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M., & Yanagisawa, N. (1995) · Annals of Neurology · doi:10.1002/ana.410370515 · Cited by 246
Structure and mechanism of mouse cysteine dioxygenase
McCoy, J. G., Bailey, L. J., Bitto, E., Bingman, C. A., Aceti, D. J., Fox, B. G., & Phillips, G. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509262103 · Cited by 210
Iron dysregulation in movement disorders
Dusek, P., Jankovic, J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 169
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Levi, S., & Finazzi, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00099 · Cited by 164
Neurodegeneration with brain iron accumulation–clinical syndromes and neuroimaging
Schipper, H. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.016 · Cited by 141
Redesigning therapies for pantothenate kinase–associated neurodegeneration
Munshi, M. I., Yao, S. J., & Ben Mamoun, C. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101577 · Cited by 32
“One hypothesis links iron imbalance to cysteine accumulation as a result of a defective PANK2 activity (16).”
Background
Metadata
- Authors
- Perry, T. L., Norman, M. G., Yong, V. W., Whiting, S., Crichton, J. U., Hansen, S., & Kish, S. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1985-10
- Volume
- 18
- Issue
- 4
- Pages
- 482-489
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1979087975
- Cited by
- 164
- References
- 0
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.